65
Participants
Start Date
June 23, 2020
Primary Completion Date
September 22, 2021
Study Completion Date
June 27, 2022
K-321 Solution
K-321 solution drops
Placebo Solution
Placebo solution drops for K-321
Sydney Eye Hospital, Sydney
Rigshospitalet - Glostrup, Glostrup Municipality
Royal Adelaide Hospital, Adelaide
Instituto de Microcirugia Ocular, Barcelona
Aarhus Universitetshospital, Aarhus
NY Langone Health, New York
Hospital La Arruzafa, Córdoba
UPMC Eye Center, Pittsburgh
Vantage EyeCare, LLC, Bala-Cynwyd
UF Health Eye Center, Gainesville
Instituto Ophthalmologic Fernandez Vega, Oviedo
Gorovoy MD Eye Specialists, Fort Myers
Cincinnati Eye Institute, Cincinnati
Price Vision Group, Indianapolis
W Kellogg Eye Center, Ann Arbor
Minnesota Eye Consultants, Bloomington
Chicago Cornea Consultants Ltd, Hoffman Estates
Arbor Centers For Eyecare, Orland Park
Universität des Saarlandes, Homburg
Eye Associates of New Mexico, Albuquerque
Jules Stein Eye Institute, Los Angeles
Universitätsklinikum Erlangen, Erlangen
Byers Eye Institute at Stanford, Palo Alto
UC Davis Eye Center, Sacramento
Devers Eye Institute, Portland
Casey Eye Institute - OHSU, Portland
Sacramento Eye Consultants, Sacramento
Massachusetts Eye and Ear Infirmary, Boston
Hospital Universitario Germans Trias i Pujol, Badalona
Lead Sponsor
Kowa Research Institute, Inc.
INDUSTRY